Bioanalysis Aims & Scope BIOANALYSIS AIMS & SCOPE
Reliable data obtained from selective, sensitive and reprodu- cible analysis of xenobiotics and biotics in biological samples is a fundamental and crucial part of every successful drug development program. The same principles can also apply to many other areas of research such as forensic science, toxicology and sports doping testing.
The bioanalytical field incorporates sophisticated tech- niques linking sample preparation and advanced separations with MS and NMR detection systems, automation and ro- botics. Standards set by regulatory bodies regarding method development and validation increasingly define the bound- aries between speed and quality.
Bioanalysis is a progressive discipline for which the future holds many exciting opportunities to further reduce sample volumes, analysis cost and environmental impact, as well as to improve sensitivity, specificity, accuracy, efficiency, assay throughput, data quality, data handling and processing.
The journal Bioanalysis focuses on the techniques and meth- ods used for the detection or quantitative study of analytes in human or animal biological samples. Bioanalysis encour- ages the submission of articles describing forward-looking applications, including biosensors, microfluidics, miniaturized analytical devices, and new hyphenated and multi-dimen- sional techniques.
Bioanalysis delivers essential information in concise, at- a-glance article formats. Key advances in the field are reported and analyzed by international experts, provid- ing an authoritative but accessible forum for the modern bioanalyst.
Principal themes include:
„„Analyte extraction and sample preparation, including microsampling
„„Chromatography and separation sciences
„„MS, NMR and other key detection methods, including ligand binding assays
„„Drug and metabolite assays
„„Biomarker assays, diagnostic assays and test kits
„„Method development and validation ap- proaches
„„Innovative bioanalytical methods and new instrumentation and equipment
„„Laboratory automation and efficiency „„Regulatory and compliance issues „„Data processing and management
Audience
The content is uniquely targeted to those working on the bioanalysis of drugs, metabolites and endogenous sub- stances in biological matrices. This is, primarily, bioanalysts working in pharmaceutical research and development in industry and academia, clinical laboratories, clinical toxic- ologists, forensic toxicologists and sports doping analysts. The articles will also have wide appeal to analytical chemists, pharmacologists, clinical chemists, and those involved with metabolomics studies.
The journal welcomes unsolicited article proposals.
ADVERTISING IN BIOANALYSIS We offer a range of print and online advertising options with attractive introductory rates and package deals available. If you would like to know more about advertising in Bioanalysis or require a quotation, please contact
Dionne Murray:
d.murray@
future-science.com SUBSCRIPTION OPTIONS
Institutional subscriptions Bioanalysis is available in print, electronic or print and electronic formats, and pricing will depend on your organization type (academic, corporate, hospital, etc). Please contact
info@future-science.com for more details.
Global e-access licenses are available on request and attract considerable discounts from standard site license fees. For further details on global access licenses, please contact
info@future-science.com
Consortia pricing Bioanalysis welcomes discussion with all consortia, and offers flexible packages and discounted prices. If you have specific questions or would like a quote please contact
info@future-science.com for more details.
future science group
www.future-science.com
S111
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117
